Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report

<p>Abstract</p> <p>Background</p> <p>Cardio toxicity due to interferon therapy was reported only in small case series or case reports. The most frequent cardiac adverse effects related to interferon are arrhythmias and ischemic manifestations. The cardiomyopathy and per...

Full description

Bibliographic Details
Main Authors: Gliga Smaranda, Arama Victoria, Popescu Cristina
Format: Article
Language:English
Published: BMC 2011-03-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/11/30
_version_ 1818114703221587968
author Gliga Smaranda
Arama Victoria
Popescu Cristina
author_facet Gliga Smaranda
Arama Victoria
Popescu Cristina
author_sort Gliga Smaranda
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Cardio toxicity due to interferon therapy was reported only in small case series or case reports. The most frequent cardiac adverse effects related to interferon are arrhythmias and ischemic manifestations. The cardiomyopathy and pericarditis are rare but can be life threatening. The predisposing factors for interferon cardio toxicity were described only for ischemic manifestations and arrhythmias.</p> <p>Case presentation</p> <p>The authors report a case of pericarditis due to alpha interferon therapy for chronic hepatitis C, in a young woman without previous cardiac pathology. The clinical manifestations started during the 7-th month of interferon treatment. The cessation of interferon was necessary. After interferon discontinuation the patient recovered, with complete resolution of pericarditis. The patient scored 9 points on the Naranjo ADR probability scale, indicating a very probable association between pericarditis and interferon administration.</p> <p>Conclusion</p> <p>If a patient receiving interferon therapy complains of chest pain of sudden onset, a cardiac ultrasound should be performed in order to rule out pericarditis. We point out the possibility of an infrequent but severe adverse effect of interferon therapy.</p>
first_indexed 2024-12-11T03:54:56Z
format Article
id doaj.art-d39ff4972b2645fa87ba5d442e6ba598
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-11T03:54:56Z
publishDate 2011-03-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-d39ff4972b2645fa87ba5d442e6ba5982022-12-22T01:21:49ZengBMCBMC Gastroenterology1471-230X2011-03-011113010.1186/1471-230X-11-30Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case reportGliga SmarandaArama VictoriaPopescu Cristina<p>Abstract</p> <p>Background</p> <p>Cardio toxicity due to interferon therapy was reported only in small case series or case reports. The most frequent cardiac adverse effects related to interferon are arrhythmias and ischemic manifestations. The cardiomyopathy and pericarditis are rare but can be life threatening. The predisposing factors for interferon cardio toxicity were described only for ischemic manifestations and arrhythmias.</p> <p>Case presentation</p> <p>The authors report a case of pericarditis due to alpha interferon therapy for chronic hepatitis C, in a young woman without previous cardiac pathology. The clinical manifestations started during the 7-th month of interferon treatment. The cessation of interferon was necessary. After interferon discontinuation the patient recovered, with complete resolution of pericarditis. The patient scored 9 points on the Naranjo ADR probability scale, indicating a very probable association between pericarditis and interferon administration.</p> <p>Conclusion</p> <p>If a patient receiving interferon therapy complains of chest pain of sudden onset, a cardiac ultrasound should be performed in order to rule out pericarditis. We point out the possibility of an infrequent but severe adverse effect of interferon therapy.</p>http://www.biomedcentral.com/1471-230X/11/30
spellingShingle Gliga Smaranda
Arama Victoria
Popescu Cristina
Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
BMC Gastroenterology
title Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
title_full Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
title_fullStr Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
title_full_unstemmed Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
title_short Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
title_sort acute pericarditis due to pegylated interferon alpha therapy for chronic hcv hepatitis case report
url http://www.biomedcentral.com/1471-230X/11/30
work_keys_str_mv AT gligasmaranda acutepericarditisduetopegylatedinterferonalphatherapyforchronichcvhepatitiscasereport
AT aramavictoria acutepericarditisduetopegylatedinterferonalphatherapyforchronichcvhepatitiscasereport
AT popescucristina acutepericarditisduetopegylatedinterferonalphatherapyforchronichcvhepatitiscasereport